SIC 2834 – Pharmaceutical Preparations
| Valuation | |
|---|---|
| Market Cap ($M) | 166.31 |
| Enterprise Value ($M) | 336.07 |
| Book Value ($M) | -171.95 |
| Book Value / Share | -1.78 |
| Price / Book | -0.97 |
| NCAV ($M) | -188.02 |
| NCAV / Share | -1.94 |
| Price / NCAV | -0.88 |
| Profitability (mra) | |
|---|---|
| Return on Invested Capital (ROIC) | -0.75 |
| Return on Assets (ROA) | -0.60 |
| Return on Equity (ROE) | n/a |
| Liquidity (mrq) | |
|---|---|
| Quick Ratio | 4.68 |
| Current Ratio | 4.92 |
| Balance Sheet (mrq) ($M) | |
|---|---|
| Current Assets | 333.00 |
| Assets | 349.08 |
| Liabilities | 521.02 |
| Debt | n/a |
| Equity | n/a |
| Income Statement (mra) ($M) | |
|---|---|
| Revenue | 0.00 |
| Operating Income | 0.00 |
| Net Income | 0.00 |
| Cash Flow Statement (mra) ($M) | |
|---|---|
| Cash From Operations | 0.00 |
| Cash from Investing | 0.00 |
| Cash from Financing | 0.00 |
(click for more detail) |
|
| File Date | Form | Activist 13D/G Investors | Ownership (%) |
Change (%) |
|---|---|---|---|---|
| 13G/A | Redmile Group, LLC | 16.20 | 2.22 | |
| 13G/A | Prosight Management, LP | 9.96 | 48.75 | |
| 13G | Oaktree Capital Group Holdings GP, LLC | 5.19 | ||
| 13D/A | Auven Therapeutics Holdings Lp | 2.70 | -64.37 | |
| 13G/A | Astrazeneca Plc | 4.88 | 0.00 |
| Top 13F Investors | Shares (1000) |
Change (%) |
Value ($1000) |
Change (%) |
|---|---|---|---|---|
(click for more detail) |
||||
| Date | Insider Trades | Code | Shares | Value |
|---|---|---|---|---|
(click for more detail) |
||||
| File Date | Form | SEC Filings |
|---|---|---|
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q | ||
| UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K | ||
(click for more detail) |
||
| Short Volume | |||
|---|---|---|---|
| Market Date | Short Volume | Total Volume | Short Volume Ratio |
| 109,001 | 384,630 | 28.34 | |
| 180,726 | 556,455 | 32.48 | |
| 224,319 | 705,242 | 31.81 | |
(click for more detail) |
|||
| Similar Companies | |
|---|---|
| ABBV – AbbVie Inc. | ABT – Abbott Laboratories |
| ANRO – Alto Neuroscience, Inc. | ANVS – Annovis Bio, Inc. |
Financial data and stock pages provided by
Fintel.io